⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5807409 | 0.79 | POLB (0.39) | — | |
| SCHEMBL5807413 | 0.79 | POLB (0.39) | — | |
| SCHEMBL17714494 | 0.77 | SIRT2 (0.48) | — | |
| SCHEMBL6616749 | 0.77 | — | — | |
| Hydantoin SCHEMBL5651123 | 0.74 | CRBN (0.39) | — | |
| SCHEMBL12838822 | 0.73 | GAA (0.45) | — | |
| SCHEMBL8997540 | 0.73 | KDM4E (0.41) | — | |
| SCHEMBL10507305 | 0.71 | — | — | |
| Thiobarbituric SCHEMBL16027 | 0.67 | — | — | |
| SCHEMBL8991935 | 0.65 | LMNA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020159407-A1 | PIGMENT FOR PROTECTIVE ELEMENTS OF MULTI-LAYERED ARTICLES BASED ON SUBSTITUTED NICKEL DITHIOLENE COMPLEXES WITH ASYMMETRICAL LIGANDS | Акционерное общество "Гознак" (АО "Гознак") | 2020-08-06 | — | — | WO | claimed |
| US-7265139-B2 | RXR activating molecules | INCYTE SAN DIEGO INC. (US) | 2007-09-04 | — | — | US | claimed |
| US-7226940-B2 | Substituted heterocycles for the treatment of diabetes and other diseases | INCYTE SAN DIEGO, INC. (US) | 2007-06-05 | — | — | US | claimed |
| US-20060004059-A1 | Substituted heterocycles for the treatment of diabetes and other diseases | PFAHL MAGNUS | 2006-01-05 | — | — | US | claimed |
| US-6974826-B2 | Imidazolidinedione derivatives for the treatment of diabetes and other diseases | INCYTE SAN DIEGO INC. (US) | 2005-12-13 | — | — | US | claimed |
| EP-1593677-A2 | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes | Incyte San Diego Incorporated (US) | 2005-11-09 | — | — | EP | claimed |
| EP-1377559-A4 | RXR ACTIVATING MOLECULES | INCYTE SAN DIEGO INC (US) | 2005-09-28 | — | — | EP | claimed |
| US-20050209286-A1 | RXR activating molecules | PFAHL MAGNUS | 2005-09-22 | — | — | US | claimed |
| EP-1214304-B1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | INCYTE SAN DIEGO INC (US) | 2005-08-24 | — | — | EP | claimed |
| US-20050070581-A1 | Imidazolidinedione derivatives for the treatment of diabetes and other diseases | INCYTE SAN DIEGO, INC. | 2005-03-31 | — | — | US | claimed |
| EP-1377559-A2 | RXR ACTIVATING MOLECULES | Maxia Pharmaceuticals, Inc. (US) | 2004-01-07 | — | — | EP | claimed |
| US-20030105333-A1 | RXR activating molecules | MAXIA PHARMACEUTICALS, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2002072543-A2 | RXR ACTIVATING MOLECULES | MAXIA PHARMACEUTICALS, INC. (US) | 2002-09-19 | — | — | WO | claimed |
| EP-1214305-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| EP-1214304-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| WO-2001016122-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| WO-2001016123-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| US-4256819-A | MEROCYANINES | EASTMAN KODAK COMPANY (US) | 1981-03-17 | — | — | US | claimed |
| US-4210715-A | TETRAZOLIUM COMPOUND AND SENSITIZING DYE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1980-07-01 | — | — | US | claimed |
| EP-4387969-A1 | SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2023213626-A1 | USE OF (5S)-3-[3-(3-CHLORO-2-FLUOROPHENOXY)-6-METHYLPYRIDAZIN-4-YL]-5-(2-CHLORO-4-METHYLBENZYL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE FOR CONTROLLING UNWANTED MICROORGANISMS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023020963-A1 | SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-23 | — | — | WO | disclosed |
| CN-108727270-B | Preparation method of 2-thioimidazolidine-4, 5-diketone | 南京信息工程大学 | 2021-04-20 | — | — | CN | disclosed |
| WO-2020159407-A1 | PIGMENT FOR PROTECTIVE ELEMENTS OF MULTI-LAYERED ARTICLES BASED ON SUBSTITUTED NICKEL DITHIOLENE COMPLEXES WITH ASYMMETRICAL LIGANDS | Акционерное общество "Гознак" (АО "Гознак") | 2020-08-06 | — | — | WO | disclosed |
| CN-108727270-A | A kind of preparation method of 2- thiocarbamoyl imidazoles alkane -4,5- diketone | 南京信息工程大学 | 2018-11-02 | — | — | CN | disclosed |
| EP-3010889-B1 | ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2018-10-03 | — | — | EP | disclosed |
| US-9981928-B2 | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-05-29 | — | — | US | disclosed |
| US-20160130240-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-05-12 | — | — | US | disclosed |
| EP-3010889-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2016-04-27 | — | — | EP | disclosed |
| EP-2916652-A1 | LIQUID POLYMER SUSPENSIONS | Rhodia Operations (FR) | 2015-09-16 | — | — | EP | disclosed |
| WO-2014202505-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2014-12-24 | — | — | WO | disclosed |
| WO-2014072429-A1 | LIQUID POLYMER SUSPENSIONS | RHODIA OPERATIONS (FR) | 2014-05-15 | — | — | WO | disclosed |
| EP-2547204-A2 | ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS | Bayer Intellectual Property GmbH (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-7265139-B2 | RXR activating molecules | INCYTE SAN DIEGO INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-7265139-B2 | RXR activating molecules | INCYTE SAN DIEGO INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-7226940-B2 | Substituted heterocycles for the treatment of diabetes and other diseases | INCYTE SAN DIEGO, INC. (US) | 2007-06-05 | — | — | US | disclosed |
| US-7153875-B2 | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | INCYTE SAN DIEGO (US) | 2006-12-26 | — | — | US | disclosed |
| US-7141596-B2 | Inhibitors of proteins that bind phosphorylated molecules | INCYTE CORPORATION (US) | 2006-11-28 | — | — | US | disclosed |
| US-7135492-B2 | Increases the concentration of high density lipoprotein cholesterol in the blood; dyslipoproteinemia; angina pectoris, myocardial infarction, antiarrhythmia agents, heart failure, kidney failure stroke, peripheral arterial occulsion | WYETH (US) | 2006-11-14 | — | — | US | disclosed |
| US-7115620-B2 | 1,3-disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers | WYETH (US) | 2006-10-03 | — | — | US | disclosed |
| EP-1643993-A2 | SUBSTITUTED ISOCHROMAN COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS, CANCER AND OTHER DISEASES | Incyte San Diego Incorporated (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20060004059-A1 | Substituted heterocycles for the treatment of diabetes and other diseases | PFAHL MAGNUS | 2006-01-05 | — | — | US | disclosed |
| US-6974826-B2 | Imidazolidinedione derivatives for the treatment of diabetes and other diseases | INCYTE SAN DIEGO INC. (US) | 2005-12-13 | — | — | US | disclosed |
| US-20050272778-A1 | Inhibitors of proteins that bind phosphorylated molecules | INCYTE CORPORATION | 2005-12-08 | — | — | US | disclosed |
| EP-1593677-A2 | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes | Incyte San Diego Incorporated (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-1377559-A4 | RXR ACTIVATING MOLECULES | INCYTE SAN DIEGO INC (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20050209286-A1 | RXR activating molecules | PFAHL MAGNUS | 2005-09-22 | — | — | US | disclosed |
| EP-1385465-A4 | HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES | INCYTE SAN DIEGO INC (US) | 2005-09-07 | — | — | EP | disclosed |
| EP-1214304-B1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | INCYTE SAN DIEGO INC (US) | 2005-08-24 | — | — | EP | disclosed |
| WO-2005035551-A2 | INHIBITORS OF PROTEINS THAT BIND PHOSPHORYLATED MOLECULES | INCYTE CORPORATION (US) | 2005-04-21 | — | — | WO | disclosed |
| US-20050070581-A1 | Imidazolidinedione derivatives for the treatment of diabetes and other diseases | INCYTE SAN DIEGO, INC. | 2005-03-31 | — | — | US | disclosed |
| US-20050038098-A1 | Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases | INCYTE CORPORATION | 2005-02-17 | — | — | US | disclosed |
| WO-2004093809-A2 | SUBSTITUTED ISOCHROMAN COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS, CANCER AND OTHER DISEASES | INCYTE SAN DIEGO INCORPORATED (US) | 2004-11-04 | — | — | WO | disclosed |
| US-6765013-B2 | ANTIPROLIFERATIVE AGENTS FOR TREATING ADIPOCYTE DIFFERENTIATION, CANCER, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, CROHN'S DISEASE OR INFLAMMATORY BOWEL DISEASE | INCYTE SAN DIEGO | 2004-07-20 | — | — | US | disclosed |
| EP-1385465-A2 | HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES | Incyte San Diego, Inc. (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-1377559-A2 | RXR ACTIVATING MOLECULES | Maxia Pharmaceuticals, Inc. (US) | 2004-01-07 | — | — | EP | disclosed |
| US-20030153606-A1 | Thiazolidinedione derivatives for the treatment of diabetes and other diseases | MAXIA PHARMACEUTICALS, INC. | 2003-08-14 | — | — | US | disclosed |
| US-20030119889-A1 | 1,3-Disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis | WYETH | 2003-06-26 | — | — | US | disclosed |
| US-20030119890-A1 | 1,3-Disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers | WYETH (US) | 2003-06-26 | — | — | US | disclosed |
| US-20030105333-A1 | RXR activating molecules | MAXIA PHARMACEUTICALS, INC. | 2003-06-05 | — | — | US | disclosed |
| US-6515003-B1 | Useful in the treatment of diseases related to lipid and carbohydrate metabolism | MAXIA PHARMACEUTICALS, INC. | 2003-02-04 | — | — | US | disclosed |
| US-20020143182-A1 | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | INCYTE GENOMICS, INC. | 2002-10-03 | — | — | US | disclosed |
| WO-2002072543-A2 | RXR ACTIVATING MOLECULES | MAXIA PHARMACEUTICALS, INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| WO-2002072009-A2 | HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES | MAXIA PHARMACEUTICALS, INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| US-6444615-B1 | COMPOUNDS EFFECTIVE AS PREEMERGENT AND POSTEMERGENT HERBICIDES | DOW AGROSCIENCES LLC | 2002-09-03 | — | — | US | disclosed |
| US-6444615-B1 | COMPOUNDS EFFECTIVE AS PREEMERGENT AND POSTEMERGENT HERBICIDES | DOW AGROSCIENCES LLC | 2002-09-03 | — | — | US | disclosed |
| EP-1214305-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| EP-1214304-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| JP-2001354660-A | HERBICIDE | ROHM & HAAS CO | 2001-12-25 | — | — | JP | disclosed |
| EP-1157991-A3 | Herbicidal imidazolidinetrione and thioxo-imidazolidinediones | Dow AgroSciences LLC (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-1157991-A2 | Herbicidal imidazolidinetrione and thioxo-imidazolidinediones | Dow AgroSciences LLC (US) | 2001-11-28 | — | — | EP | disclosed |
| EP-1157991-A2 | Herbicidal imidazolidinetrione and thioxo-imidazolidinediones | Dow AgroSciences LLC (US) | 2001-11-28 | — | — | EP | disclosed |
| WO-2001016123-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016122-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| US-RE30457-E | HISTAMINE RECEPTOR ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-12-23 | — | — | US | disclosed |
| US-4152453-A | HISTAMINE RECEPTOR ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-05-01 | — | — | US | disclosed |
| US-4152453-A | HISTAMINE RECEPTOR ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-05-01 | — | — | US | disclosed |